Royce & Associates’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,777,894
Closed -$1.01M 811
2025
Q1
$1.01M Sell
1,777,894
-187,220
-10% -$106K 0.01% 667
2024
Q4
$4.15M Buy
1,965,114
+513,664
+35% +$1.08M 0.04% 522
2024
Q3
$3.9M Buy
1,451,450
+10,000
+0.7% +$26.9K 0.04% 520
2024
Q2
$4.11M Buy
1,441,450
+92,671
+7% +$264K 0.04% 513
2024
Q1
$5.72M Sell
1,348,779
-102,050
-7% -$433K 0.05% 465
2023
Q4
$7.76M Buy
1,450,829
+40,200
+3% +$215K 0.07% 386
2023
Q3
$6.07M Buy
1,410,629
+9,800
+0.7% +$42.1K 0.06% 430
2023
Q2
$7.69M Sell
1,400,829
-38,353
-3% -$211K 0.07% 386
2023
Q1
$6.04M Buy
1,439,182
+14,319
+1% +$60.1K 0.06% 445
2022
Q4
$3.95M Sell
1,424,863
-73,400
-5% -$203K 0.04% 527
2022
Q3
$3.84M Sell
1,498,263
-122,000
-8% -$312K 0.04% 503
2022
Q2
$5.83M Sell
1,620,263
-65,700
-4% -$237K 0.06% 431
2022
Q1
$10.5M Sell
1,685,963
-127,200
-7% -$790K 0.09% 344
2021
Q4
$12.8M Sell
1,813,163
-5,160
-0.3% -$36.4K 0.1% 337
2021
Q3
$12.7M Sell
1,818,323
-195,627
-10% -$1.37M 0.09% 343
2021
Q2
$16.8M Buy
2,013,950
+96,000
+5% +$800K 0.12% 306
2021
Q1
$10.5M Buy
1,917,950
+252,350
+15% +$1.38M 0.07% 436
2020
Q4
$7.15M Buy
1,665,600
+71,875
+5% +$308K 0.06% 469
2020
Q3
$4.8M Sell
1,593,725
-280,875
-15% -$845K 0.05% 481
2020
Q2
$5.81M Buy
1,874,600
+193,600
+12% +$600K 0.06% 420
2020
Q1
$3.72M Buy
1,681,000
+30,000
+2% +$66.3K 0.05% 457
2019
Q4
$5.04M Sell
1,651,000
-216,400
-12% -$660K 0.05% 491
2019
Q3
$5.74M Buy
1,867,400
+37,600
+2% +$116K 0.05% 452
2019
Q2
$3.66M Buy
1,829,800
+99,600
+6% +$199K 0.03% 567
2019
Q1
$7.46M Hold
1,730,200
0.06% 403
2018
Q4
$5.5M Buy
1,730,200
+130,500
+8% +$415K 0.05% 477
2018
Q3
$8.4M Buy
1,599,700
+34,700
+2% +$182K 0.06% 450
2018
Q2
$8.37M Buy
1,565,000
+270,306
+21% +$1.45M 0.06% 446
2018
Q1
$6.47M Sell
1,294,694
-202,406
-14% -$1.01M 0.05% 493
2017
Q4
$4.94M Sell
1,497,100
-60,500
-4% -$200K 0.03% 589
2017
Q3
$5.84M Hold
1,557,600
0.04% 534
2017
Q2
$3.97M Hold
1,557,600
0.03% 660
2017
Q1
$4.05M Buy
1,557,600
+44,000
+3% +$114K 0.03% 647
2016
Q4
$4.62M Sell
1,513,600
-147,400
-9% -$450K 0.03% 600
2016
Q3
$4.52M Buy
1,661,000
+115,000
+7% +$313K 0.03% 623
2016
Q2
$4.42M Hold
1,546,000
0.03% 624
2016
Q1
$4.67M Buy
1,546,000
+225,000
+17% +$680K 0.03% 627
2015
Q4
$4.58M Sell
1,321,000
-600
-0% -$2.08K 0.03% 639
2015
Q3
$5M Buy
1,321,600
+1,400
+0.1% +$5.29K 0.03% 645
2015
Q2
$7.53M Buy
1,320,200
+535,400
+68% +$3.05M 0.03% 634
2015
Q1
$4.57M Buy
784,800
+10,000
+1% +$58.2K 0.02% 766
2014
Q4
$4.39M Hold
774,800
0.02% 809
2014
Q3
$3.17M Buy
774,800
+7,700
+1% +$31.5K 0.01% 912
2014
Q2
$3.49M Hold
767,100
0.01% 939
2014
Q1
$3.64M Hold
767,100
0.01% 946
2013
Q4
$3.61M Sell
767,100
-244,705
-24% -$1.15M 0.01% 959
2013
Q3
$4.04M Hold
1,011,805
0.01% 903
2013
Q2
$3.63M Buy
+1,011,805
New +$3.63M 0.01% 930